These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10803406)

  • 21. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
    HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/delta32ccr5 heterozygotes.
    Edelstein RE; Arcuino LA; Hughes JP; Melvin AJ; Mohan KM; King PD; McLellan CL; Murante BL; Kassman BP; Frenkel LM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Dec; 16(4):243-6. PubMed ID: 9402070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCR5 genotypes and progression to HIV disease in perinatally infected children.
    de Angelis DS; Freire WS; Pannuti CS; Succi RC; Machado DM
    Braz J Infect Dis; 2007 Apr; 11(2):196-8. PubMed ID: 17625759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of the CCR5Delta32 mutation in Brazilian populations and cell susceptibility to HIV-1 infection.
    Grimaldi R; Shindo N; Acosta AX; Dourado I; Brites C; de Melo Carvalho O; Brito I; Bou-Habib DC; Galvão-Castro B
    Hum Genet; 2002 Jul; 111(1):102-4. PubMed ID: 12136242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32.
    Henrich TJ; Hanhauser E; Hu Z; Stellbrink HJ; Noah C; Martin JN; Deeks SG; Kuritzkes DR; Pereyra F
    AIDS; 2015 May; 29(8):867-76. PubMed ID: 25730507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children.
    Ometto L; Bertorelle R; Mainardi M; Zanchetta M; Tognazzo S; Rampon O; Ruga E; Chieco-Bianchi L; De Rossi A
    J Infect Dis; 2001 Mar; 183(5):814-8. PubMed ID: 11181160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 32-nucleotide deletion, associated with defence against hiv/aids, is a predominant mutation of CCR5 gene in the population of Georgia.
    Kamkamidze G; Capoulade-Metay C; Butsashvili M; Dudoit Y; Chubinishvili O; Debre P; Theodorou L
    Georgian Med News; 2005 Jan; (118):74-9. PubMed ID: 15821335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of a 32 bp deletion in the gene for human immunodeficiency virus 1 co-receptor CCR5 in Slovak population.
    Takácová M; Nogová P; Hábeková M; Staneková D
    Acta Virol; 2008; 52(4):261-4. PubMed ID: 19143484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of CCR5-delta32 heterozygosity on the risk of perinatal HIV-1 infection: a meta-analysis.
    Contopoulos-Ioannidis DG; O'Brien TR; Goedert JJ; Rosenberg PS; Ioannidis JP
    J Acquir Immune Defic Syndr; 2003 Jan; 32(1):70-6. PubMed ID: 12514416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of TNF-alpha genetic variants and CCR5 Delta 32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards.
    Veloso S; Olona M; García F; Domingo P; Alonso-Villaverde C; Broch M; Peraire J; Viladés C; Plana M; Pedrol E; López-Dupla M; Aguilar C; Gutiérrez M; Leon A; Tasias M; Gatell JM; Richart C; Vidal F
    BMC Med Genet; 2010 Apr; 11():63. PubMed ID: 20420684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
    Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
    Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.
    Woitas RP; Ahlenstiel G; Iwan A; Rockstroh JK; Brackmann HH; Kupfer B; Matz B; Offergeld R; Sauerbruch T; Spengler U
    Gastroenterology; 2002 Jun; 122(7):1721-8. PubMed ID: 12055576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.
    Teixeira SL; Bastos FI; Hacker MA; Morgado MG
    Infect Genet Evol; 2009 Jul; 9(4):638-42. PubMed ID: 19460331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
    Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32.
    Ballana E; Riveira-Munoz E; Pou C; Bach V; Parera M; Noguera M; Santos JR; Badia R; Casadellà M; Clotet B; Paredes R; Martínez MA; Brander C; Esté JA
    Immunobiology; 2013 Apr; 218(4):543-7. PubMed ID: 22818666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion.
    Sheppard HW; Celum C; Michael NL; O'Brien S; Dean M; Carrington M; Dondero D; Buchbinder SP
    J Acquir Immune Defic Syndr; 2002 Mar; 29(3):307-13. PubMed ID: 11873082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of CCR-5 delta32 allele in Argentinian children at risk of HIV-1 infection: its role in vertical transmission.
    Mangano A; Prada F; Roldán A; Picchio G; Bologna R; Sen L
    AIDS; 1998 Jan; 12(1):109-10. PubMed ID: 9456261
    [No Abstract]   [Full Text] [Related]  

  • 39. CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report.
    Duarte RF; Salgado M; Sánchez-Ortega I; Arnan M; Canals C; Domingo-Domenech E; Fernández-de-Sevilla A; González-Barca E; Morón-López S; Nogues N; Patiño B; Puertas MC; Clotet B; Petz LD; Querol S; Martinez-Picado J
    Lancet HIV; 2015 Jun; 2(6):e236-42. PubMed ID: 26423196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
    Singh KK; Barroga CF; Hughes MD; Chen J; Raskino C; McKinney RE; Spector SA
    J Infect Dis; 2003 Nov; 188(10):1461-72. PubMed ID: 14624371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.